Modified monitoring of abiraterone acetate-induced hepatotoxicity in prostate cancer patients
Journal of Oncology Pharmacy Practice
Published online on October 17, 2024
Abstract
Journal of Oncology Pharmacy Practice, Volume 32, Issue 3, Page 466-471, April 2026.
IntroductionAbiraterone is a standard treatment for prostate cancer and is a preferred treatment option at the Veterans Affairs North Texas Health Care System (VANTXHCS) due to its formulation, cost, and overall tolerability. In the combined data of five ...
IntroductionAbiraterone is a standard treatment for prostate cancer and is a preferred treatment option at the Veterans Affairs North Texas Health Care System (VANTXHCS) due to its formulation, cost, and overall tolerability. In the combined data of five ...